Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Markus Müschen, MD, PhD, Yale University Read More
In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Ron Levy, MD, Stanford University School of Medicine Read More
Detection and Targeting of Enzymatic Base Editing Deregulation in Leukemia Stem Cells 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Catriona Jamieson, MD, PhD, University of California San Diego Read More
The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School Read More
T-Cell Acute Lymphoblastic Leukemia Accumulation in the Central Nervous System 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Susan R. Schwab, PhD, New York University Read More
Rational Therapeutic Targeting of Oncogenic Immune Signaling States in Myeloid Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Daniel T. Starczynowski, PhD, Cincinnati Children's Research Foundation Read More